#OBSChristmasRun2019

Does the loss of taste/smell with #COVID19 indicate a nerve tropism or incidental nerve damage?

A cohort of patients with severe Covid-19 received treatment with remdesivir under a compassionate-use protocol. Improvement in oxygen-support status was observed in 68% of patients, and overall mortality was 13% over a median follow-up of 26 days. #COVID19

Just in NEJM: Compassionate use of Remdesivir, a viral RNA polymerase inhibitor, results in clinical improvement in 68% hospitalized patients (n=61) with severe COVID-19 infection. bit.ly/3b0DHDM Hoping for a positive randomized trial needed down the line. ASCO Publications

Less than 3 years after we enrolled the first patient on the #RET inhibitor clinical trial, the drug Selpercatinib has been approved by the U.S. FDA for RET + #lungcancer and #thyroidcancer ! Alexander Drilon MD David Hyman Nathan A. Pennell MD, PhD, FASCO Justin Gainor Vamsi Velcheti, MD MBA FASCO

Happy to share our work showing that the #AffordableCareAct saved lives. This work will be presented at #ASCO20 "This is the first study to show the benefit of Medicaid expansion on cancer death rates on a national scale." @sloan_kettering Duke Cancer asco.org/about-asco/pre…

#ASCO20 Results from 3 large phase III registration trials (Prosper/Spartan/Aramis) in non-metastatic (M0)CRPC published on ASCO meeting website today: Enza/ Apa/ Daro, all show OS benefit. Great news for our patients. ASCO Publications The ASCO Post Weblink: shorturl.at/bcpDK

Thrilled to have another abstract with my good friend Sumanta K. Pal, MD, FASCO. Hopefully we'll get to work together again in the future! #ASCO20

Im really enjoying reading all the #ASCO20 abstracts and tweets. Makes me feel like I'm right there with all of you!

Today, this new preprint from John Ioannidis (of "Most Published Research Findings Are False" fame) went online Already up to Altmetric of 541 Let's do a rapid peer-review on twitter 1/n

just when we thought we were out of the woods...

What will it take for us to stop rewarding abusive mentors? #QuestionsIShouldntHaveToAsk

Just Now, study from England linking Primary care records of 17,278,392 adults to 10,926 #COVID19-related deaths. COVID-19 and Cancer Consortium (CCC19) Registry Matthew Katz, MD 🇺🇸🟦 Mike Thompson, MD, PhD, FASCO gilberto lopes Vivek Subbiah, MD chadi nabhan MD, MBA, FACP Stephanie Graff, MD, FACP, FASCO @NarjustDumaMD Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) Sumanta K. Pal, MD, FASCO Tatiana Prowell, MD nature.com/articles/s4158…

1/ There are various tweets misinterpreting COVID-19 “pre-existing immunity” and making dangerous claims about herd immunity. Since many of those claims refer to our scientific papers, we will reiterate the facts. Alessandro Sette La Jolla Institute Science Magazine Cell

Hi Charles Ryan ! Great to (virtually) see you.

How do you know what information on the Internet you can trust when it comes to cancer treatment? Learn about evaluating cancer info by following CancerDotNet & visiting ow.ly/Q8h230r7ea3 #cancertreatment #cancersupport #medicalmisinfo #misinformation

Happy to announce that I'm joining the awesome team at Terray Therapeutics as Director of Oncology. Less happy to announce that I'm leaving New Zealand in a few weeks to do so. It was too exciting of an opportunity to pass up!

Excited to share the results of SWOG Cancer Research Network 1500, which we are presenting at ASCO #GU21 & reporting in The Lancet today. 1st, THANK YOU to patients & families. 2nd, hats off to a tremendous group of investigators. This was a team effort! Wanted to share how it all began: (1/13)